Data spanning the past 90 days through December 12, 2025 reveals that Aurinia Pharmaceuticals's three principal insider shareholders consist of Director Kevin Tang (11.33Mn shares), Director Daniel Billen (28.14K shares), Director Jeffrey Allen Bailey (22.77K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Kevin Tang | 11,329,500 | 05 Aug, 2025 | |
| Peter Greenleaf | Chief Executive Officer | 1,788,945 | 04 Mar, 2025 |
| Matthew Maxwell Donley | Chief Operating Officer | 680,465 | 04 Mar, 2025 |
| Joseph M Miller | Chief Financial Officer | 577,361 | 04 Mar, 2025 |
| Stephen P. Robertson | EVP And General Counsel | 509,276 | 04 Mar, 2025 |
| Scott Michael Habig | Chief Commercial Officer | 456,338 | 08 Aug, 2024 |
| Volker Knappertz | EVP And Research And Development | 319,128 | 29 Feb, 2024 |
| Michael Robert Martin | Chief Business Officer | 259,162 | 06 Mar, 2023 |
| Greg Keenan | Chief Medical Officer | 133,484 | 05 Aug, 2025 |
| Michael R Hayden | 95,000 | 02 Feb, 2021 | |
| Neil Solomons | Chief Medical Officer | 90,953 | 04 Mar, 2022 |
| George M Jr Milne | 78,733 | 23 May, 2023 | |
| Robert Bindert Huizinga | EVP Of Research | 69,379 | 04 Mar, 2022 |
| David R.W. Jayne | 56,499 | 25 Nov, 2024 | |
| Daniel Billen | 28,141 | 22 May, 2024 | |
| Jill Leversage | 25,453 | 25 Nov, 2024 | |
| Karen L. Smith | 24,807 | 25 Nov, 2024 | |
| Jeffrey Allen Bailey | 22,775 | 24 Nov, 2025 | |
| R. Hector Mackay-Dunn | 18,595 | 22 May, 2024 | |
| Brinda Balakrishnan | 17,523 | 22 May, 2024 | |
| Craig A Johnson | 14,592 | 24 Nov, 2025 | |
| Massimilano Colao | Chief Commercial Officer | 13,495 | 04 Mar, 2022 |
| Joseph P Hagan | 11,961 | 23 May, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 21 Nov, 2025 | Jeffrey Allen Bailey | Common Shares | D | 2,716 | $15.68 | 22,775 | D | F |
| 21 Nov, 2025 | Craig A Johnson | Common Shares | D | 6,039 | $15.68 | 14,592 | D | F |
| 01 Aug, 2025 | Greg Keenan | Common Stock | D | 20,000 | $10.50 | 133,484 | D | S |
| 01 Aug, 2025 | Kevin Tang | Common Shares | A | 1,000,000 | $10.12 | 11,029,500 | I | P |
| 01 Aug, 2025 | Greg Keenan | - | - | 133,484 | D | |||
| 04 Aug, 2025 | Kevin Tang | Common Shares | A | 100,000 | $11.34 | 11,129,500 | I | P |
| 04 Aug, 2025 | Kevin Tang | - | - | 11,129,500 | I | |||
| 05 Aug, 2025 | Kevin Tang | Common Shares | A | 200,000 | $11.68 | 11,329,500 | I | P |
| 05 Aug, 2025 | Kevin Tang | - | - | 11,329,500 | I | |||
| 07 Mar, 2025 | Greg Keenan | Common Stock | D | 8,305 | $8.23 | 153,484 | D | S |
| 28 Feb, 2025 | Kevin Tang | Common Shares | A | 399,280 | $7.85 | 8,828,780 | I | P |
| 28 Feb, 2025 | Matthew Maxwell Donley | Common Stock | A | 82,781 | $0.00 | 669,791 | D | A |
| 28 Feb, 2025 | Stephen P. Robertson | Common Stock | A | 84,106 | $0.00 | 529,349 | D | A |
| 28 Feb, 2025 | Peter Greenleaf | Common Stock | A | 290,728 | $0.00 | 1,815,780 | D | A |
| 28 Feb, 2025 | Joseph M Miller | Common Stock | A | 81,457 | $0.00 | 580,663 | D | A |
| 28 Feb, 2025 | Matthew Maxwell Donley | - | - | 669,791 | D | |||
| 28 Feb, 2025 | Greg Keenan | Common Stock | A | 62,583 | $0.00 | 174,028 | D | A |
| 03 Mar, 2025 | Matthew Maxwell Donley | - | - | 805,358 | D | |||
| 03 Mar, 2025 | Greg Keenan | Common Stock | D | 12,239 | $8.00 | 161,789 | D | S |
| 03 Mar, 2025 | Joseph M Miller | Common Stock | A | 114,711 | $0.00 | 695,374 | D | A |